Table 3.
FACE-Q scales | Pre-OGS group | Post-OGS group | Control group | Pre-OGS group vs Post-OGS group |
Post-OGS group vs Control group |
Pre-OGS group vs Control group |
---|---|---|---|---|---|---|
p-value | p-value | p-value | ||||
Appearance appraisal scales | ||||||
Facial appearance overall | 44.52 ± 19.36 (0–100) | 68.06 ± 20.38 (35–100) | 56.51 ± 16.01 (19–93) | <0.01 | <0.01 | <0.01 |
Cheeks | 46.02 ± 19.13 (0–100) | 66.11 ± 21.11 (30–100) | 60.67 ± 20.84 (0–100) | <0.01 | <0.01 | <0.01 |
Cheekbones | 68.05 ± 22.23 (11–95) | 74.83 ± 21.53 (25–100) | 72.00 ± 20.94 (0–100) | <0.01 | >0.05 | <0.01 |
Chin | 35.57 ± 22.91 (0–87) | 67.83 ± 18.56 (57–100) | 64.18 ± 24.55 (0–100) | <0.01 | <0.01 | <0.01 |
Under chin | 69.52 ± 19.75 (30–100) | 83.00 ± 15.23 (42–100) | 77.77 ± 18.01 (30–100) | <0.01 | <0.01 | <0.01 |
Lower face and jawline | 35.11 ± 26.72 (0–100) | 72.32 ± 21.00 (34–100) | 63.74 ± 23.24 (0–100) | <0.01 | <0.01 | <0.01 |
Nose | 44.16 ± 26.15 (0–100) | 59.79 ± 24.54 (0–100)a | 59.93 ± 19.48 (35–100) | <0.01 | >0.05 | <0.01 |
Nostrils | 46.57 ± 25.70 (0–100) | 59.11 ± 28.52 (0–100)a | 67.56 ± 24.73 (0–100) | <0.01 | <0.01 | <0.01 |
Lips | 47.00 ± 21.41 (0–100) | 64.79 ± 22.17 (25–100) | 66.16 ± 19.24 (32–100) | <0.01 | >0.05 | <0.01 |
Quality-of-life scales | ||||||
Social function | 42.89 ± 21.66 (0–100) | 56.72 ± 23.59 (0–100)a | 54.53 ± 21.65 (9–100) | <0.01 | >0.05 | <0.01 |
Psychological well-being | 53.16 ± 24.21 (5–100) | 66.42 ± 23.09 (36–100) | 69.74 ± 21.26 (23–100) | <0.01 | <0.01 | <0.01 |
Early life impact | – | 76.40 ± 25.81 (26–100) | – | – | – | – |
Patient experience scales | ||||||
Outcome | – | 71.35 ± 21.65 (0–100)a | – | – | – | – |
Decision | – | 76.66 ± 22.24 (33–100) | – | – | – | – |
Medical team | – | 91.26 ± 15.24 (53–100) | – | – | – | – |
Office staff | – | 89.62 ± 17.04 (33–100) | – | – | – | – |
Surgeon | – | 91.92 ± 16.14 (37–100) | – | – | – | – |
Data are presented as mean ± standard deviation (range); Abbreviations: OGS: orthognathic surgery; Pre-OGS group: subjects with no history of OGS; Post-OGS group: subjects with history of OGS; –: not applicable.
One (social function and outcome scales) and three (nose and nostril scales) patients had zero values.